Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.55
-0.35 (-1.85%)
At close: Dec 18, 2025, 4:00 PM EST
18.55
0.00 (0.00%)
After-hours: Dec 18, 2025, 4:03 PM EST
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.65 billion as of December 18, 2025. Its market cap has decreased by -11.13% in one year.
Market Cap
2.65B
Enterprise Value
1.97B
1-Year Change
-11.13%
Ranking
Category
Stock Price
$18.55
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.65B, an increase of 234.81%. That is a compound annual growth rate of 25.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 2.70B | 12.59% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |